Objective
ConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about the safety of medication use in pregnancy and lactation.
What do we deliver? ConcePTION aims to create a paradigm shift in how we study medication safety in pregnancy. We will establish (1) a successful, sustainable open-science based EU non-proprietary ecosystem of public and private stakeholders, pregnant women and researchers to generate and disseminate timely and reliable evidence on drugs across maternal, neonatal and long term outcomes of medication exposure in pregnancy and breastfeeding (2) a catalogue with fully characterized data sources for rapid selection of suitable data sources; 3) operational, business, network, information and data governance models, (4) quality assured and tested methodological approaches, analytical tools and data platforms allowing for distributed analyses, (5) procedures and tools for collection of digital data and samples directly from pregnant women, (6) In vitro, in silico and in vivo models for prediction of drug transfer in human milk, (7) a biobank and analytical network for quantification of drug in human milk, (8) best practice documents endorsed by regulators and health authorities and (9) a web-based drug information knowledge bank.
How do we deliver? (1) Experienced leaders, able to manage challenging networks and public-public or public-private partnerships. (2) Defragmentation by connecting all key stakeholders and EU networks in this area. (3) Re-use of data, tools and foreground from prior European commission funded projects. (4) Connecting to leaders of similar initiatives in the USA, Canada, Asia and other parts of the world. (5) Systematic consensus & endorsement building. (6) Quality throughout as a precondition to trust the results and information by all users.
Field of science
- /natural sciences/biological sciences/ecology/ecosystems
- /medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drug
- /medical and health sciences/clinical medicine/obstetrics and gynaecology/obstetrics
Call for proposal
H2020-JTI-IMI2-2017-13-two-stage
See other projects for this call
Funding Scheme
IMI2-RIA - Research and Innovation action











Coordinator
3584 CX Utrecht
Netherlands
Participants (52)
BT52 1SA Coleraine
751 05 Uppsala
8010 Graz
40126 Bologna
1853 Strombeek-bever
3000 Leuven
E14 4PU London
5237 MH S Hertogenbosch
50141 Firenze
17177 Stockholm
NE7 7DN Newcastle-upon-tyne
3630 Westville
0313 Oslo
SW17 0RE London
2 Dublin
9713 GZ Groningen
5721 HW Asten
75654 Paris
9140 Temse
31052 Toulouse Cedex 3
44121 Ferrara
SA2 8PP Swansea
Participation ended
1211 Geneve
1050 Brussels
1050 Bruxelles
5237MH Hertogenbosch
M13 9PL Manchester
104 22 Stockholm
3584 BH Utrecht
00271 Helsinki
00185 Roma
46010 Valencia
3584 BL Utrecht
3721 MA Bilthoven
1083 HS Amsterdam
2340 Beerse
4056 Basel
91380 Chilly Mazarin
Participation ended
WC2B 4AE London
TW89GS Brentford
RG24 9NL Basingstoke
CT13 9NJ Sandwich
10154 New York
64293 Darmstadt
2880 Bagsvaerd
1070 Bruxelles
60064 North Chicago Il
4261 Dalmose
HG3 IPY Harrogate
49131 Petach Tivka
1011 Lausanne
8152 Glattpark